PartnerFacts
Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 6:53 AM ET

Sponsor Check › Sponsor group

E

Exodos

One sponsor team, 2 deal companies · Chapel Hill, NC

Grouped because: 4 shared people, same business address (2 issuers) (automatic match from the filings) · not the same sponsor?

2deal companies
$1.04Mreported sold
48investors
7Form D filings
2011–2016active
0new, last 12 mo
Follow this sponsor groupLook further ↓

Data last updated Oct 23, 2026, 5:45 PM ET · Latest filing in this group Apr 19, 2016 · Courts (RECAP) last checked: Oct 24, 2026, 2:16 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET

The short version

Exodos is a sponsor group of 2 issuers that PartnerFacts links to one sponsor (shared people, same person name on both filings, same business address; automatic match from the filings), filing 7 Form D filings between Nov 2011 and Apr 2016.

What this means One team, 2 deal companies, about 5 years of track record in SEC filings. We link the companies because the same people or address appear on their forms — tap "Request a correction" if that is wrong.

Combined reported sold: $1.04M to 48 investors (latest filing per issuer). Industries as reported: Pharmaceuticals (1), Other Health Care (1). Issuers are based in NC (2).

What this means $1.04M raised across the group, about $22K per investor. Amounts come from each company's latest Form D; they are what the sponsor reported, not audited figures.

Principal people: Crist Frangakis (2 issuers, executive officer and director), Jerry Rosenblatt (2 issuers, director), Ron Vered (2 issuers, director), William Dickie (2 issuers, director) and William Bauer (1 issuer, director).

What this means The person on the most companies is usually the one running the show; their page lists every deal.

Activity: 0 new offerings in the last 12 months; latest filing Apr 19, 2016.

What this means No new raise filed in the past year.

Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, LA, ME, MO, MS, MT, NASAA, NC, NH, NM, OR, RI, TX, WA), property records (NYC, FL, IL and TX counties) — none found.

What this means Nothing turned up where we looked (4 sources). That does not prove there is nothing — it means none was found in those sources on that date.

We compared 7 public filings for Exodos and found 12 differences, 2 worth asking the sponsor about: 6 filings report more than 10% of the money raised going to insiders; 4 Form Ds were filed more than 15 days after the first sale; and more below.

What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.

What the community is saying

Community search for Exodos has not run yet — it is joining a line of 21,463 names; searches run around the clock at the hosts' allowed rate. Searched so far: 363 names.

Community comments are quoted as written by their authors. Sources searched: BiggerPockets forums (via DuckDuckGo, Brave, Bing and BiggerPockets search) and Reddit (search feed + public archive).

Key records

Five things investors ask first. Items still in human review are counted, not shown.

1. Lawsuits

None found in sources searched — federal courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 2:16 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: NV (crawled Oct 23, 2026)

What was searched

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched Exodos..

State securities regulators: Securities regulators searched (3,318 actions): AZ Corporation Commission Securities Division (411 actions, 2017–2026), CA DFPI (25 actions, 2007–2024; listing starts 2002), DE DOJ Investor Protection Unit (257 actions, 1987–2026), TX State Securities Board (586 actions, 2006–2026), WA DFI (2,039 actions, 2001–2026) — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first — last crawled Oct 23, 2026, 9:57 PM ET. No machine-readable public listing today for IA, IN, KS, MI, NE, NV (see docs/state-regulators.md).

3. Bankruptcies

None found in sources searched — federal bankruptcy courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 2:16 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

4. Differences between public sources

No comparisons published

What is compared

No public statement by this sponsor group has been collected yet, so there is nothing to compare. Sources compared: the sponsor's own website (known from the issuer's own filings — Form C issuer website, EDGAR company profile — an approved profile claim or Form ADV Item 1.I of its matched adviser) · SEC Form D · SEC Form ADV (IAPD) · Internet Archive · No website is on file for this sponsor group yet.

12 differences found between the filings for Exodos — 2 worth asking about (compared 7 filings on Oct 24, 2026)

Worth asking · Nov 4, 2011 – Mar 13, 2014

6 filings report more than 10% of the money raised going to insiders

27% of the money raised went to insiders — Achelios Therapeutics, Inc. · 66% of the money raised went to insiders — Exodos Life Sciences Limited Partnership · 200% of the money raised went to insiders — Exodos Life Sciences Limited Partnership · 30% of the money raised went to insiders — Exodos Life Sciences Limited Partnership · 22% of the money raised went to insiders — Achelios Therapeutics, Inc. · and 1 more

What this means The filing reports how much of the money raised was paid to insiders. Over 10% is high for most deals. Ask what it paid for.

Form D · Feb 21, 2012 ↗Achelios Therapeutics, Inc. — PartnerFacts page ↗Form D/A · Nov 30, 2011 ↗Exodos Life Sciences Limited Partnership — PartnerFacts page ↗
Sources
Worth asking · Aug 3, 2010 – Mar 12, 2014

4 Form Ds were filed more than 15 days after the first sale

Form D filed 129 days after the first sale — Exodos Life Sciences Limited Partnership · Form D filed 458 days after the first sale — Exodos Life Sciences Limited Partnership · Form D filed 36 days after the first sale — Exodos Life Sciences Limited Partnership · Form D filed 18 days after the first sale — Achelios Therapeutics, Inc.

What this means Late notices are common and carry no penalty by themselves. A pattern of late paperwork is worth asking the sponsor about.

Form D · Nov 17, 2011 ↗Exodos Life Sciences Limited Partnership — PartnerFacts page ↗Form D · Nov 4, 2011 ↗Form D · Mar 12, 2014 ↗
Sources
Note · Apr 7, 2016 – Apr 19, 2016

No amendment in the last 12 months on an offering that may still be open — Achelios Therapeutics, Inc. (latest filing Apr 19, 2016)

The latest filing for this offering is dated Apr 19, 2016 (first sale Apr 7, 2016). It reports $350,000 sold of $2,000,000 offered. No later amendment is in our index as of Oct 24, 2026.

What this means SEC rules expect a yearly amendment while an offering is still going. The raise may simply have ended — a Form D does not say when it closed. Ask the sponsor whether the offering closed, when, and at what amount.

Form D · Apr 19, 2016 ↗Achelios Therapeutics, Inc. — PartnerFacts page ↗
Sources
Note · Feb 3, 2012 – Mar 13, 2014

No amendment in the last 12 months on an offering that may still be open — Achelios Therapeutics, Inc. (latest filing Mar 13, 2014)

The latest filing for this offering is dated Mar 13, 2014 (first sale Feb 3, 2012). It reports $3,170,442 sold of $4,250,000 offered. No later amendment is in our index as of Oct 24, 2026.

What this means SEC rules expect a yearly amendment while an offering is still going. The raise may simply have ended — a Form D does not say when it closed. Ask the sponsor whether the offering closed, when, and at what amount.

Form D/A · Mar 13, 2014 ↗Achelios Therapeutics, Inc. — PartnerFacts page ↗
Sources
Note · Feb 4, 2014 – Mar 12, 2014

No amendment in the last 12 months on an offering that may still be open — Exodos Life Sciences Limited Partnership (latest filing Mar 12, 2014)

The latest filing for this offering is dated Mar 12, 2014 (first sale Feb 4, 2014). It reports $688,249 sold of $1,000,000 offered. No later amendment is in our index as of Oct 24, 2026.

What this means SEC rules expect a yearly amendment while an offering is still going. The raise may simply have ended — a Form D does not say when it closed. Ask the sponsor whether the offering closed, when, and at what amount.

Form D · Mar 12, 2014 ↗Exodos Life Sciences Limited Partnership — PartnerFacts page ↗
Sources
Note · Feb 21, 2012 – Mar 13, 2014

Crist Frangakis's role changed at Achelios Therapeutics, Inc.: executive officer → executive officer, director

The Feb 21, 2012 filing lists Crist Frangakis as executive officer; the Mar 13, 2014 Form D/A lists executive officer, director.

What this means Roles on Form D are self-reported by the issuer. A change can mean a real change in who runs the company, or just a different box ticked. Ask who makes decisions today.

Form D · Feb 21, 2012 ↗Form D/A · Mar 13, 2014 ↗Crist Frangakis — PartnerFacts page ↗Achelios Therapeutics, Inc. — PartnerFacts page ↗
Sources
Note · Nov 30, 2011 – Mar 12, 2014

Crist Frangakis's role changed at Exodos Life Sciences Limited Partnership: executive officer → director

The Nov 30, 2011 filing lists Crist Frangakis as executive officer; the Mar 12, 2014 Form D lists director.

What this means Roles on Form D are self-reported by the issuer. A change can mean a real change in who runs the company, or just a different box ticked. Ask who makes decisions today.

Form D/A · Nov 30, 2011 ↗Form D · Mar 12, 2014 ↗Crist Frangakis — PartnerFacts page ↗Exodos Life Sciences Limited Partnership — PartnerFacts page ↗
Sources
Note · Feb 21, 2012 – Mar 13, 2014

Offering amount changed between filings — Achelios Therapeutics, Inc.

The Feb 21, 2012 filing says $3,000,000 offered; the Mar 13, 2014 Form D/A says $4,250,000.

What this means The target raise changed. Raising the cap is common when a deal grows; ask whether the extra money has the same terms and use.

Form D (earlier) · Feb 21, 2012 ↗Form D/A (later) · Mar 13, 2014 ↗Achelios Therapeutics, Inc. — PartnerFacts page ↗
Sources
Note · Nov 17, 2011 – Nov 30, 2011

Offering amount changed between filings — Exodos Life Sciences Limited Partnership

The Nov 17, 2011 filing says $500,000 offered; the Nov 30, 2011 Form D/A says $760,550.

What this means The target raise changed. Raising the cap is common when a deal grows; ask whether the extra money has the same terms and use.

Form D (earlier) · Nov 17, 2011 ↗Form D/A (later) · Nov 30, 2011 ↗Exodos Life Sciences Limited Partnership — PartnerFacts page ↗
Sources
Note · Nov 4, 2011 – Mar 13, 2014

Crist Frangakis is written 2 different ways on the filings

listed as "Crist Frangakis" on 5 filings (from Nov 4, 2011), and "Crist J. Frangakis" on 2 filings (from Mar 13, 2014).

What this means Same person, written differently — a middle name or suffix left off, or spelled another way. It is normal, but check that the full legal name matches your subscription documents.

Form D · Nov 4, 2011 ↗Form D/A · Mar 13, 2014 ↗Crist Frangakis — PartnerFacts page ↗
Sources
Note · Feb 21, 2012 – Apr 19, 2016

Industry group changed between filings — Achelios Therapeutics, Inc.

"Pharmaceuticals" (Feb 21, 2012 to Mar 13, 2014); then "Other Health Care" (Apr 19, 2016).

What this means The issuer described its business differently on different forms. Often it is just a different box ticked; sometimes the deal itself changed. Ask which business your money is in.

Form D · Feb 21, 2012 ↗Form D · Apr 19, 2016 ↗Achelios Therapeutics, Inc. — PartnerFacts page ↗
Sources
Note · Feb 21, 2012 – Apr 19, 2016

Issuer used a different name before — Achelios Therapeutics, Inc.

SEC records list prior names for this filer: Achelios Therapeutics LLC; Achelios Therapeutics. The current name on file is "Achelios Therapeutics, Inc.".

What this means A name change is normal, but your documents may show the old name. Match the CIK, not just the name.

EDGAR filer page ↗Achelios Therapeutics, Inc. — PartnerFacts page ↗
Sources
What is compared

What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. As of Oct 24, 2026.

5. Money to insiders

0 of 5 offerings report sales commissions; 0 report finder's fees; 4 report proceeds to related persons totalling $1,600,000. (includes amounts the issuer reported as estimates)

Offering (latest filing)Sales commissionsFinder's feesTo insidersPaid to sell itSource
Apr 19, 2016 D
Achelios Therapeutics, Inc.
File 021-261596
$0$0$0
Proceeds will be used for working capital, which will include normal compensation to executive officers.
None listed on this filingEDGAR ↗
Mar 13, 2014 D/A
Achelios Therapeutics, Inc.
File 021-173716
$0$0$700,000 (est.)None listed on this filingEDGAR ↗
Mar 12, 2014 D
Exodos Life Sciences Limited Partnership
File 021-213430
$0$0$100,000 (est.)None listed on this filingEDGAR ↗
Nov 30, 2011 D/A
Exodos Life Sciences Limited Partnership
File 021-168863
$0$0$500,000None listed on this filingEDGAR ↗
Nov 4, 2011 D
Exodos Life Sciences Limited Partnership
File 021-168238
$0$0$300,000None listed on this filingEDGAR ↗
How this is counted

Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across all 2 issuers in this group — every filing in our index, latest filing per offering (SEC file number).

Property records 0 documents · 0 ownership records · last checked Oct 24, 2026, 6:52 AM ET · NYC and Cook County lookup still to run

0 recorded documents and 0 ownership records matched to Exodos in the sources searched.

Not found in sources searched as of Oct 24, 2026, 6:52 AM ET: Hillsborough County FL Clerk of Court Official Records daily index (publicrec.hillsclerk.com D/P/M files), 2 daily files (Oct 14, 2026 to Oct 15, 2026) — loaded Oct 23, 2026, 8:59 PM ET; Harris County TX (HCAD ownership rolls 2023–2026) — 432,532 records, loaded Oct 24, 2026, 6:52 AM ET; Dallas County TX (DCAD ownership roll 2026) — 173,688 records, loaded Oct 23, 2026, 8:58 PM ET; Hillsborough County FL (FL DOR 2026 ownership roll + Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026), Miami-Dade County FL (FL DOR 2026 ownership roll) — 294,950 records, loaded Oct 23, 2026, 8:58 PM ET. Still to be looked up for this group: NYC ACRIS via NYC Open Data (Real Property Parties 636b-3b5g, Master bnx9-e6tj, Legals 8h5j-fqxa, Document Control Codes 7isb-wh4c) · NYC PLUTO ownership via NYC Open Data (64uk-42ks) · Cook County IL Assessor via Cook County Open Data (Parcel Sales wvhk-k5uv; Parcel Addresses 3723-97qp). Records in other counties, and recorder indexes we do not yet cover, were not searched.

Property records coverage: New York City (ACRIS recorded documents and PLUTO ownership, looked up per issuer when its page is viewed; re-checked when the page is viewed again more than 30 days after the last check); Harris County TX (ownership only, no deed, mortgage or sale records; HCAD ownership rolls 2023–2026); Dallas County TX (ownership only, no deed, mortgage or sale records; DCAD ownership roll 2026); Hillsborough County FL (FL DOR 2026 ownership roll + Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026), Miami-Dade County FL (FL DOR 2026 ownership roll); Cook County IL (assessor ownership and deed/sale records, looked up per issuer when its page is viewed). Recorder indexes (party names on deeds, mortgages and liens) in TX, AZ, NV, CA and WA counties and outside the Clerk index in FL, mortgages and liens outside NYC and Hillsborough County, lis pendens and foreclosure notices everywhere, Los Angeles County CA, Clark County NV, King County WA (loader ready; first load not finished), Cook County IL bulk pass (not finished; per-issuer lookups only so far), New York City bulk pass (not finished; per-issuer lookups only so far), Maricopa County AZ (loader ready; commercial-purpose statement not yet filed), Salt Lake County UT, and all other counties are not covered — not searched. Last refresh by source: Harris County Appraisal District real_acct.txt Oct 24, 2026, 6:52 AM ET; Hillsborough County FL Clerk daily index Oct 23, 2026, 8:59 PM ET; Dallas Central Appraisal District ACCOUNT_INFO.CSV Oct 23, 2026, 8:58 PM ET; Florida DOR NAL roll (Dade 23) Oct 23, 2026, 8:58 PM ET; Florida DOR NAL roll (Hillsborough 39) Oct 23, 2026, 8:54 PM ET. NYC and Cook County are also looked up per issuer when its page is viewed; the most recent such lookup on this site finished Oct 24, 2026, 3:30 AM ET. Parties are named as the recorder's index names them (role suffixes as recorded); no address, account number or trust date is shown for an individual, and individual owners of record (home ownership) are not matched or shown. Items still in human review are not shown.

Issuers in this group

Why each issuer is here is stated in the "Linked by" column. Low-confidence links are never shown — they wait for human review.

SourceIssuerLinked byLocationIndustryFilingsSold (max)InvestorsMin. investment (latest filing)Active
EDGAR ↗EL Exodos Life Sciences Limited Partnershipshared people, same person name on both filings, same business addressChapel Hill, NCPharmaceuticals4$1,000,000
offering $1,000,000 · similar: $1,694,259–$16,000,000
15
similar: 1–13
No minimum reported
similar: $10,000–$55,000
2011–2014
EDGAR ↗AT Achelios Therapeutics, Inc.shared people, same person name on both filings, same business addressCHAPEL HILL, NCOther Health Care3$3,170,442
offering $2,000,000 · similar: $829,831–$9,999,998
33
similar: 2–15
No minimum reported
similar: $10,000–$54,310
2012–2016

"Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pharmaceuticals / 506(b) (800 filings); Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Timeline of offerings

SourceFiledIssuerFormIndustryOfferedSold
EDGAR ↗Apr 19, 2016Achelios Therapeutics, Inc.DOther Health Care$2,000,000$350,000
EDGAR ↗Mar 13, 2014Achelios Therapeutics, Inc.D/APharmaceuticals$4,250,000$3,170,442
EDGAR ↗Mar 12, 2014Exodos Life Sciences Limited PartnershipDPharmaceuticals$1,000,000$688,249
EDGAR ↗Feb 21, 2012Achelios Therapeutics, Inc.DPharmaceuticals$3,000,000$1,856,004
EDGAR ↗Nov 30, 2011Exodos Life Sciences Limited PartnershipD/APharmaceuticals$760,550$760,550
EDGAR ↗Nov 17, 2011Exodos Life Sciences Limited PartnershipDPharmaceuticals$500,000$250,000
EDGAR ↗Nov 4, 2011Exodos Life Sciences Limited PartnershipDPharmaceuticals$1,000,000$1,000,000

Activity: 0 new offerings in the last 12 months across all issuers in this group (new offering = a Form D that is not an amendment, D/A) · most recent filing Apr 19, 2016. Industry history, as reported on each offering's latest filing: Previous offerings: Pharmaceuticals (2011–2014). Latest offering: Other Health Care (Apr 19, 2016).

People across the group

NameRolesIssuers hereFirst → last listed
CF Crist FrangakisExecutive Officer, Director2Nov 4, 2011 → Apr 19, 2016
RV Ron VeredDirector2Mar 12, 2014 → Apr 19, 2016
JR Jerry RosenblattDirector2Mar 12, 2014 → Apr 19, 2016
WD William DickieDirector2Mar 12, 2014 → Mar 13, 2014
WB William BauerDirector1Mar 13, 2014 → Mar 13, 2014

Adviser registration (Form ADV)

Searched SEC Form ADV bulk data (registered + exempt reporting advisers) (24,962 records as of Oct 2, 2026, 8:00 AM ET) — nothing matched Exodos.

Meta advertising

No Meta Pixel ids or Facebook / Instagram page links on file for Exodos as of Oct 24, 2026 — the sponsor website is read for them once it is on file (runs automatically). Meta Ad Library: not searched by PartnerFacts (no API access); a one-tap Ad Library search is under Look further.

Other offering types (Regulation A and Regulation Crowdfunding)

Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.

Public profiles and social

No website or social profile named in Exodos's SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #288,847 of 374,652 in line (561 issuers searched so far). One-tap searches: Look further ↓

Export this report as PDF · Premium

Request diligence pack (Premium) PartnerFacts asks the sponsor for the standard information pack and delivers it to you labelled "provided by the sponsor".

Change history

No corrections have been requested for this page.

Request a correction

Free. Covers the grouping itself or any record shown here. Logged with status: received → under review → fixed / confirmed with source.

Sponsor response

Add a sourced explanation next to any fact. Reviewed before publishing.

Grouping is PartnerFacts' inference from public filings (shared related persons, management entities, business address). Everything else on this page is drawn from the filings themselves. Not the same sponsor? Request a correction.

Look further

One-tap searches on sites we do not index ourselves, with the name pre-filled (outside the US (as filed: CHAPEL HILL), NC). Each opens in a new tab; what you find there is not verified by PartnerFacts.

Social and web

LinkedIn companies ↗Instagram ↗X (Twitter) ↗Facebook ↗YouTube ↗Google ↗Google Images ↗Google News ↗Meta Ad Library ↗

Courts

CourtListener / RECAP (federal) ↗PACER case locator (federal, login) ↗North Carolina eCourts portal ↗

Securities regulators

SEC EDGAR full-text search ↗SEC action look-up ↗FINRA BrokerCheck ↗SEC IAPD adviser search ↗

Business registries

North Carolina Secretary of State business search ↗OpenCorporates ↗